These insights reveal whether your biology will respond better to semaglutide, tirzepatide, or dual-compound therapy, allowing your doctor to select the single most effective agent rather than combining drugs
According to Arcutis press release, Zoryve is the first drug in more than two decades with a new mechanism of action for seborrheic dermatitis, a skin condition affecting primarily the scalp
GLP-1 medications, also called GLP-1 receptor agonists, are medicines that act like a natural hormone called glucagon-like peptide-1
[DOI] [PMC free article] [PubMed] [Google Scholar] 23.Wennig R., Eyer F., Schaper A., Zilker T., Andresen-Streichert H
Tanya Kormeili, a board-certified dermatologist and dermatologic surgeon in Santa Monica, for complex skin concerns including scarring disorders